Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update

BMC Gastroenterology · Published 2026-07-25 · DOI 10.1186/s12876-026-04804-7

Free full text

Authors (6)

Jeanne Jiang, Abigail Wojtowicz, Jennifer Uyei, He Jin, Kristina Lindsley, Marie Sanchirico

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Jiang, J., Wojtowicz, A., Uyei, J., et al. (2026). Comparative efficacy and safety of subcutaneous vedolizumab versus other targeted inflammatory bowel therapies in patients with moderate to severe ulcerative colitis: a network meta-analysis update. BMC Gastroenterology. https://doi.org/10.1186/s12876-026-04804-7

Related articles